0001209191-15-056200.txt : 20150625 0001209191-15-056200.hdr.sgml : 20150625 20150625142126 ACCESSION NUMBER: 0001209191-15-056200 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150618 FILED AS OF DATE: 20150625 DATE AS OF CHANGE: 20150625 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZS Pharma, Inc. CENTRAL INDEX KEY: 0001459266 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263305698 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 508 WRANGLER DRIVE, SUITE 100 CITY: COPPELL STATE: TX ZIP: 75019 BUSINESS PHONE: 650-458-4100 MAIL ADDRESS: STREET 1: 508 WRANGLER DRIVE, SUITE 100 CITY: COPPELL STATE: TX ZIP: 75019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KEYSER D JEFFREY CENTRAL INDEX KEY: 0001393516 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36489 FILM NUMBER: 15951500 MAIL ADDRESS: STREET 1: 4848 LOOP CENTRAL DRIVE STREET 2: SUITE 700 CITY: HOUSTON STATE: TX ZIP: 77081 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-06-18 0 0001459266 ZS Pharma, Inc. ZSPH 0001393516 KEYSER D JEFFREY 805 VETERANS BLVD, SUITE 300 REDWOOD CITY CA 94063 0 1 0 0 See Remarks Employee Stock Options 2015-06-18 4 A 0 16875 55.57 A Common Stock 16875 16875 D Restricted Stock Unit 2015-06-18 4 A 0 3000 0.00 A Common Stock 3000 3000 D Dr. Keyser was granted an option to purchase 16,875 shares of common stock at an exercise price per share of $55.57 on June 18, 2015, of which 25% of the shares subject to such option will vest on the first anniversary of the date of grant, with the remaining 75% of the shares vesting monthly in substantially equal installments over the following 36 months, subject to Dr. Keyser's continuing to provide services to the company and to the terms of the option agreement accompanying the grant. On June 18, 2015, Dr. Keyser was granted 3,000 restricted stock units representing the right to receive one share of common stock upon vesting of each restricted stock unit. The restricted stock units vest over four years, with 25% vesting on each of the first four anniversaries of the date of grant, subject to Dr. Keyser's continuing to provide services to the company on each vesting date. Chief Operating Officer /s/ Donald Jeffrey Keyser 2015-06-25